Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6B
pubmed:dateCreated
1996-8-7
pubmed:abstractText
The object of this study was to analyse the tissue and serum metalloproteinase (MMP-2), an enzyme which degrades the basement membrane collagen type IV, as a potential marker useful in prognostic evaluation and clinical monitoring of the follow-up, in patients with advanced ovarian serous cystadenocarcinoma.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0250-7005
pubmed:author
pubmed:issnType
Print
pubmed:volume
15
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2799-804
pubmed:dateRevised
2010-3-24
pubmed:meshHeading
pubmed-meshheading:8669868-Basement Membrane, pubmed-meshheading:8669868-Collagen, pubmed-meshheading:8669868-Cystadenocarcinoma, Serous, pubmed-meshheading:8669868-Cystadenoma, pubmed-meshheading:8669868-Disease-Free Survival, pubmed-meshheading:8669868-Female, pubmed-meshheading:8669868-Gelatinases, pubmed-meshheading:8669868-Humans, pubmed-meshheading:8669868-Immunoenzyme Techniques, pubmed-meshheading:8669868-Matrix Metalloproteinase 2, pubmed-meshheading:8669868-Metalloendopeptidases, pubmed-meshheading:8669868-Neoplasm Invasiveness, pubmed-meshheading:8669868-Neoplasm Proteins, pubmed-meshheading:8669868-Ovarian Neoplasms, pubmed-meshheading:8669868-Prognosis, pubmed-meshheading:8669868-Proportional Hazards Models, pubmed-meshheading:8669868-Retrospective Studies, pubmed-meshheading:8669868-Survival Analysis
pubmed:articleTitle
Tissue and serum metalloproteinase (MMP-2) expression in advanced ovarian serous cystoadenocarcinomas: clinical and prognostic implications.
pubmed:affiliation
Institute of Gynecology and Obstetrics, Ancona University, Italy.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't